Merck & Co Inc
NYSE:MRK
Merck & Co Inc
NYSE:MRK
Price:
128.26 USD
-0.42%
Market Closed
Updated:
May 3, 2024
Merck & Co Inc
Revenue
|
Merck & Co Inc
Revenue Peer Comparison
Comparables:
JNJ
BMY
PFE
ZTS
LLY
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Revenue
$8.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Merck & Co Inc
Revenue Breakdown
Breakdown by Geography
Merck & Co Inc
Merck & Co Inc
|
Total Revenue:
60.1B
USD
|
|
Int’l:
31.6B
USD
|
|
United States:
28.5B
USD
|
|
Europe, Middle East And Africa:
13.3B
USD
|
|
China:
6.8B
USD
|
|
Asia Pacific (Other Than China And Japan):
3.2B
USD
|
|
Japan:
3.2B
USD
|
|
Latin America:
3.1B
USD
|
|
Other:
2.1B
USD
|
Breakdown by Segments
Merck & Co Inc
Merck & Co Inc
Not Available
See Also
What is Merck & Co Inc's Revenue?
Revenue
61.4B
USD
61.4B
USD
Based on the financial report for Mar 31, 2024, Merck & Co Inc's Revenue amounts to 61.4B USD.
What is Merck & Co Inc's Revenue growth rate?
Revenue CAGR 10Y
3%
3%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Merck & Co Inc have been 14% over the past three years , 7% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
